从狩猎伙伴到家庭成员，狗的温顺、忠诚和善解人意，使它们赢得无数“铲屎官”的心。然而，近年来，随着一系列恶犬伤人事件的频繁发生，这一和谐景象背后隐藏的健康风险也逐渐浮出水面，引起了社会各界的广泛关注和深入讨论。对狂犬病毒的研究与防控，也成为了公共卫生领 ...

mRNA technology was quickly adopted in the COVID-19 vaccine race and has undoubtedly proven its worth. Less than a year after the emergence of COVID-19, an entirely new type of vaccine based on ...

Moderna (MRNA) reachead $53.80 at the closing of the latest trading day, reflecting a -0.55% change compared to its last close. We recently compiled a list of the 10 Best QQQ Stocks to Buy ...

This valuable study on strategies used by Pseudomonas to subvert hots immunity identifies a new immune evasion strategy. The study presents solid evidence on the cleavage of VgrG2B by Caspase 11 and ...

A team of researchers at the University of Pennsylvania took a new approach, using mRNA technology to design a multipronged vaccine that targets several proteins that underlie C. difficile’s ...

mRNA vaccines have gained widespread attention for their crucial role in fighting the COVID-19 pandemic. Yet, even before the ...

This means adults have a choice in which COVID vaccine they receive: an mRNA vaccine by Moderna or Pfizer, or Novavax, a protein-based vaccine that targets the virus in a more "traditional" way.

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines ...

GlaxoSmithKline has filed a lawsuit against Moderna, claiming its mRNA vaccines infringe on GSK's patents. GSK seeks royalties for Moderna's alleged unlicensed use of its groundbreaking vaccine ...

Dividend history information is presently unavailable for this company. This could indicate that the company has never provided a dividend or that a dividend is pending.